NanoViricides, Inc. is a biotechnology company based in Shelton, CT that is dedicated to developing nanomachine-based antiviral therapeutics. Their innovative nanoviricides are designed to target specific viruses by fooling them into attaching to the nanomachine, which then wraps around the virus, neutralizes it, and effectively destroys it. With a focus on immunotherapeutics, NanoViricides aims to revolutionize antiviral strategies and bring about a new era in targeted antiviral therapeutics. NanoViricides, Inc. is at the forefront of nanomedicine technologies, with a team of experienced scientists and researchers leading the way in drug discovery and development. Their broad-spectrum antiviral drug, NV-CoV-2, has shown promising results in clinical trials against coronaviruses, RSV, and other viral infections. With a pipeline of potential drug candidates targeting various viruses, NanoViricides is committed to addressing unmet medical needs and providing effective treatments for a range of viral diseases.
Generated from the website